相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis
Zhengtu Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Is COVID-19 receiving ADE from other coronaviruses?
Jason A. Tetro
MICROBES AND INFECTION (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Li Guo et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Wei-jie Guan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations
Le Chang et al.
EMERGING INFECTIOUS DISEASES (2020)
Prevention of transfusion-transmitted infections
Michael P. Busch et al.
BLOOD (2019)
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
Elisabeth A. van Erp et al.
FRONTIERS IN IMMUNOLOGY (2019)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M. Gunn et al.
CELL HOST & MICROBE (2018)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
J. van Griensven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
Yaseen M. Arabi et al.
EMERGING INFECTIOUS DISEASES (2016)
History of passive antibody administration for prevention and treatment of infectious diseases
Barney S. Graham et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Noninfectious Serious Hazards of Transfusion
Jeanne E. Hendrickson et al.
ANESTHESIA AND ANALGESIA (2009)
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
KM Yeh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
YOY Soo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Antibody-mediated regulation of cellular immunity and the inflammatory response
A Casadevall et al.
TRENDS IN IMMUNOLOGY (2003)
Passive antibody administration (immediate immunity) as a specific defense against biological weapons
A Casadevall
EMERGING INFECTIOUS DISEASES (2002)
分享论文
